Repligen Corporation RGEN is progressing well with its filtration and chromatography product franchisees. Based on the strength of these two businesses, this Zacks #2 Ranked company reiterated its revenue guidance for the full year.
Repligen has a VGM Score of B and a market cap of $6.28 billion. The consensus mark for its fiscal 2020 earnings stands at $1.13 per share, having moved 1.8% north over the past 30 days
Up $10.19 at an all time high.
I believe the stock could retrace back to the low 60's or even the high 50's. At the end of year they had $191 Million in cash and they are paying $192 Million plus $48 million in stock for C Technologies. So they will be cash poor. Also they will need to dilute some 800,000 shares for the $48 million in stocks. So I could see them diluting about 2 million shares to do the deal and to raise some extra cash. Eventually it will work it's way back to $69 again.
Yes, I am having a very good day. Been holding this for years.
News: $RGEN Repligen Corporation Announces Agreement to Acquire Process Analytics Innovator C Technologies and Reports Preliminary First Quarter 2019 Financial Results
Proposed acquisition establishes a key franchise for Repligen in the rapidly growing Process Analytics segment of bioprocessing Adds a market leader in protein concentration measurement with proprietary and differentiated spectroscopy technology Complements and advances our systems...
In case you are interested https://marketwirenews.com/news-releases/repligen-corporation-announces-agreement-to-acquire-process-analytics-innovator-c-technologies-and-reports-preliminary-first-quarter-2019-financial-results-8064860.html